A COMPARATIVE TRIAL OF A CONTROLLED-RELEASE FORMULATION OF KETOPROFEN (ORUVAIL) AND A CONVENTIONAL CAPSULE FORMULATION OF KETOPROFEN (ORUDIS) IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP

被引：14
|
作者：
MORLEY, KD
BERNSTEIN, RM
HUGHES, GRV
BLACK, CM
RAJAPAKSE, CNA
WILSON, L
机构：
[1] W MIDDLESEX UNIV HOSP,ISLEWORTH,ENGLAND
[2] WRIGHTINGTON HOSP,WIGAN,ENGLAND
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 1984年 / 9卷 / 01期
关键词：
D O I：
10.1185/03007998409109555
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：28 / 34
页数：7
相关论文
共 50 条
  • [31] Demonstration of the sustained anthelmintic efficacy of a controlled-release capsule formulation of ivermectin in weaner lambs under field conditions in New Zealand
    Gogolewski, RP
    Allerton, GR
    Rugg, D
    Kawhia, D
    Barrick, RA
    Eagleson, JS
    NEW ZEALAND VETERINARY JOURNAL, 1997, 45 (04) : 158 - 161
  • [32] A RANDOMIZED CONTROLLED TRIAL COMPARING HYDROTHERAPY AND CONVENTIONAL PHYSIOTHERAPY TO PATIENTS WITH HIP OSTEOARTHRITIS (HOA)
    Patru, S.
    Marcu, I. R.
    Bighea, A. C.
    Caimac, D.
    Popescu, R. S.
    Matei, D.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S255 - S255
  • [33] A COMPARATIVE-STUDY OF CONVENTIONAL AND CONTROLLED-RELEASE FORMULATIONS OF TRAZODONE IN ELDERLY DEPRESSED-PATIENTS
    BAYER, AJ
    PATHY, MSJ
    CAMERON, A
    VENKATESWALU, T
    ATHER, SA
    MANKIKAR, GD
    GHOSH, AK
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 : S50 - S55
  • [34] CONTROLLED-RELEASE INDOMETHACIN AND SUSTAINED-RELEASE DICLOFENAC SODIUM IN THE TREATMENT OF OSTEOARTHRITIS - A COMPARATIVE CONTROLLED CLINICAL-TRIAL IN GENERAL-PRACTICE
    GOSTICK, N
    JAMES, IGV
    KHONG, TK
    ROY, P
    SHEPHERD, PR
    MILLER, AJ
    CURRENT MEDICAL RESEARCH AND OPINION, 1990, 12 (03) : 135 - 142
  • [35] CS1, a controlled-release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial
    Benza, Raymond L.
    Adamson, Philip B.
    Bhatt, Deepak L.
    Frick, Fredrik
    Olsson, Gunnar
    Bergh, Niklas
    Dahlof, Bjorn
    PULMONARY CIRCULATION, 2024, 14 (01)
  • [36] COMPARISON OF THE EFFICACY AND TOLERABILITY OF KETOPROFEN (ORUVAIL) 200 MG ONCE DAILY WITH INDOMETHACIN (INDOCID-R) 75 MG TWICE DAILY IN OSTEOARTHRITIS OF THE KNEE AND HIP - A DOUBLE-BLIND, WITHIN-PATIENT, RANDOMIZED TRIAL
    HOSSAIN, MA
    CLINICAL TRIALS JOURNAL, 1990, 27 (04) : 268 - 277
  • [37] Clinical evaluation of ropinirole controlled-release formulation at 18-24 mg/day in Japanese patients with Parkinson's disease
    Hattori, Nobutaka
    Hasegawa, Kazuko
    Sato, Katsuaki
    Mitsuyama, Erika
    Numachi, Yotaro
    PARKINSONISM & RELATED DISORDERS, 2017, 40 : 33 - 39
  • [38] CONCENTRATION-EFFECT RELATIONSHIP OF LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE AFTER ORAL-ADMINISTRATION OF AN IMMEDIATE-RELEASE AND A CONTROLLED-RELEASE FORMULATION
    HARDER, S
    BAAS, H
    BERGEMANN, N
    DEMISCH, L
    RIETBROCK, S
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (01) : 39 - 44
  • [39] COMPARISON OF THE EFFECTS OF A CONTROLLED-RELEASE FORMULATION OF ISOSORBIDE-5-MONONITRATE AND CONVENTIONAL ISOSORBIDE DINITRATE ON EXERCISE PERFORMANCE IN MEN WITH STABLE ANGINA-PECTORIS
    SEABRAGOMES, R
    ALEIXO, AM
    ADAO, M
    MACHADO, FP
    MENDES, M
    BRUGES, G
    PALOS, JL
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (20): : 1308 - 1312
  • [40] Monitoring Helicoverpa assulta (Guenee) (Lepidoptera: Noctuidae) with synthetic sex pheromone and small scale disruption trial with controlled-release PVC resin formulation
    Park, KC
    Boo, KS
    Cork, A
    Hall, DR
    APPLIED ENTOMOLOGY AND ZOOLOGY, 1999, 34 (01) : 19 - 22
12345